Skip to main content
Back to News
Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia...
Technology
1 min read

Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia...

The AMW Read

Updates the healthcare/bio player map with a new agentic infrastructure launch that integrates foundation models (Anthropic) and compute (Nvidia) into a vertical workflow.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition
Owkin
Owkin

AI in Healthcare

View Company Profile

Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia and Anthropic. The flagship Pathology Explorer agent achieves 23.7% higher accuracy using 5x fewer parameters than legacy models. By leveraging multimodal data from 800+ hospitals, the system reduces biological research computation times from weeks to mere hours. This transition to autonomous reasoning marks a systemic shift toward biological super intelligence and automated discovery. 🧬

#AI #DrugDiscovery #Biotech #Innovation

Explore OwkinRead Original

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 4d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 4d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 7mo agoOwkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia... · THIS ARTICLE

More news from Owkin

Stay updated with the latest news and announcements from Owkin.

View all Owkin news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard